These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36482903)

  • 21. Characterization of m6A methylation modifications in gastric cancer.
    Yin W; Huo Z; Zuo J; Wang H; Chen B; Zhou L
    Aging (Albany NY); 2024 Jan; 16(1):89-105. PubMed ID: 38206646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy.
    Zhao K; Wei B; Zhang Y; Shi W; Zhang G; Wang Z
    Front Pharmacol; 2022; 13():1052177. PubMed ID: 36438800
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration.
    Yue Q; Zhang Y; Wang F; Cao F; Bai J; Duan X
    J Immunol Res; 2022; 2022():8766735. PubMed ID: 35692505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of m6A Methylation Modification Patterns and Tumor Immune Microenvironment in Breast Cancer.
    Dong M; Shen W; Yang G; Yang Z; Li X
    Front Cell Dev Biol; 2022; 10():785058. PubMed ID: 35178386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the expression patterns and potential prognostic role of m6A-RNA methylation regulators in Wilms Tumor.
    Jia C; Gao H; Ma W; Liu X; Chang M; Sun F
    BMC Med Genomics; 2023 Sep; 16(1):222. PubMed ID: 37735424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of m6A Regulator-Mediated Methylation Modification and Tumor Microenvironment Infiltration in Glioblastoma Multiforme.
    Wang L; Cao H; Zhong Y; Ji P; Chen F
    Front Cell Dev Biol; 2022; 10():842835. PubMed ID: 35265626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer.
    Yang Q; Xu F; Jian A; Yu H; Ye T; Hu W
    Front Cell Dev Biol; 2021; 9():803141. PubMed ID: 35198565
    [No Abstract]   [Full Text] [Related]  

  • 28. N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes.
    Wei J; Fang DL; Zhou W; He YF
    J Gastrointest Oncol; 2021 Aug; 12(4):1860-1872. PubMed ID: 34532134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. m6A modification patterns are associated with copy number burden and tumor immune landscape in thyroid cancer.
    Cai L; Liu T; Hua H; Jiang X; Qian L
    BMC Endocr Disord; 2023 Dec; 23(1):271. PubMed ID: 38057752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma.
    Ji J; Liu S; Liang Y; Zheng G
    BMC Genom Data; 2023 Aug; 24(1):44. PubMed ID: 37568073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased m6A methylation level is associated with the progression of human abdominal aortic aneurysm.
    He Y; Xing J; Wang S; Xin S; Han Y; Zhang J
    Ann Transl Med; 2019 Dec; 7(24):797. PubMed ID: 32042813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in patients with intracranial aneurysms.
    Maimaiti A; Turhon M; Cheng X; Su R; Kadeer K; Axier A; Ailaiti D; Aili Y; Abudusalamu R; Kuerban A; Wang Z; Aisha M
    Front Neurol; 2022; 13():889141. PubMed ID: 35989938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel insight into m6A regulator-mediated methylation modification patterns and immune characteristics in intracranial aneurysm.
    Li S; Zhang Q; Weng L; Han Y; Li J
    Front Aging Neurosci; 2022; 14():973258. PubMed ID: 36034129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia.
    Xu ZJ; Wen XM; Zhang YC; Jin Y; Ma JC; Gu Y; Chen XY; Xia PH; Qian W; Lin J; Qian J
    Front Genet; 2022; 13():948079. PubMed ID: 36035161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma.
    Huang ZD; Lin LL; Liu ZZ; Hu C; Gu HY; Wei RX
    Front Immunol; 2021; 12():765723. PubMed ID: 35003079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma.
    Li J; Wang W; Zhou Y; Liu L; Zhang G; Guan K; Cui X; Liu X; Huang M; Cui G; Sun R
    Front Cell Dev Biol; 2021; 9():687756. PubMed ID: 34277630
    [No Abstract]   [Full Text] [Related]  

  • 37. m6A Regulator-mediated RNA Methylation Modulates Immune Microenvironment of Hepatitis B Virus-related Acute Liver Failure.
    Li D; Liu Y; Zhou J; Chen Y; Yang C; Liu H; Li W; You J
    Inflammation; 2023 Oct; 46(5):1777-1795. PubMed ID: 37256461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia.
    Han S; Qi J; Fang K; Wang H; Tang Y; Wu D; Han Y
    Cancer Med; 2022 Mar; 11(5):1413-1426. PubMed ID: 35023630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of m6A methylation with immune infiltrates and poor prognosis in non-small cell lung cancer via a comprehensive analysis of RNA expression profiles.
    Dong B; Wu C; Li SH; Huang L; Zhang C; Wu B; Sheng Y; Liu Y; Ye G; Qi Y
    Ann Transl Med; 2021 Sep; 9(18):1465. PubMed ID: 34734017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer.
    Zhou Z; Zhang J; Xu C; Yang J; Zhang Y; Liu M; Shi X; Li X; Zhan H; Chen W; McNally LR; Fung KM; Luo W; Houchen CW; He Y; Zhang C; Li M
    EBioMedicine; 2021 Mar; 65():103271. PubMed ID: 33714027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.